230 related articles for article (PubMed ID: 21483947)
1. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor.
Nordgren IK; Tavassoli A
Chem Soc Rev; 2011 Aug; 40(8):4307-17. PubMed ID: 21483947
[TBL] [Abstract][Full Text] [Related]
2. [Hypoxia and angiogenesis].
Simon JM
Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
4. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
5. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors.
Hickey MM; Simon MC
Curr Top Dev Biol; 2006; 76():217-57. PubMed ID: 17118268
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
Otrock ZK; Hatoum HA; Awada AH; Ishak RS; Shamseddine AI
Crit Rev Oncol Hematol; 2009 May; 70(2):93-102. PubMed ID: 19186072
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.
Nguyen MP; Lee S; Lee YM
Arch Pharm Res; 2013 Mar; 36(3):252-63. PubMed ID: 23440580
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factors--regulation, role and comparative aspects in tumourigenesis.
Hansen AE; Kristensen AT; Law I; Jørgensen JT; Engelholm SA
Vet Comp Oncol; 2011 Mar; 9(1):16-37. PubMed ID: 21303451
[TBL] [Abstract][Full Text] [Related]
10. [Hypoxia in cancer malignity. Review].
Arvelo F; Cotte C
Invest Clin; 2009 Dec; 50(4):529-46. PubMed ID: 20306726
[TBL] [Abstract][Full Text] [Related]
11. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors.
Arjamaa O; Nikinmaa M
Exp Eye Res; 2006 Sep; 83(3):473-83. PubMed ID: 16750526
[TBL] [Abstract][Full Text] [Related]
12. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression.
Cosse JP; Michiels C
Anticancer Agents Med Chem; 2008 Oct; 8(7):790-7. PubMed ID: 18855580
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factors: a central link between inflammation and cancer.
Triner D; Shah YM
J Clin Invest; 2016 Oct; 126(10):3689-3698. PubMed ID: 27525434
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factors and cancer.
Calzada MJ; del Peso L
Clin Transl Oncol; 2007 May; 9(5):278-89. PubMed ID: 17525038
[TBL] [Abstract][Full Text] [Related]
15. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
[TBL] [Abstract][Full Text] [Related]
16. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
17. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases.
Vavilala DT; Ponnaluri VK; Vadlapatla RK; Pal D; Mitra AK; Mukherji M
Biochem Biophys Res Commun; 2012 Jun; 422(3):369-74. PubMed ID: 22580280
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species and HIF-1 signalling in cancer.
Galanis A; Pappa A; Giannakakis A; Lanitis E; Dangaj D; Sandaltzopoulos R
Cancer Lett; 2008 Jul; 266(1):12-20. PubMed ID: 18378391
[TBL] [Abstract][Full Text] [Related]
19. The ever-expanding role of HIF in tumour and stromal biology.
LaGory EL; Giaccia AJ
Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
